Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14006
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pingaew R. | |
dc.contributor.author | Worachartcheewan A. | |
dc.contributor.author | Nantasenamat C. | |
dc.contributor.author | Prachayasittikul S. | |
dc.contributor.author | Ruchirawat S. | |
dc.contributor.author | Prachayasittikul V. | |
dc.date.accessioned | 2021-04-05T03:32:50Z | - |
dc.date.available | 2021-04-05T03:32:50Z | - |
dc.date.issued | 2013 | |
dc.identifier.issn | 2536269 | |
dc.identifier.other | 2-s2.0-84884209513 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14006 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884209513&doi=10.1007%2fs12272-013-0111-9&partnerID=40&md5=aa028d5f7130164b379dd96d7e28b416 | |
dc.description.abstract | 1-Substituted-N-tosyl-1,2,3,4-tetrahydroisoquinoline analogs (4a-4l) were synthesized using the modified Pictet-Spengler reaction and evaluated for cytotoxicity. All tetrahydroisoquinolines displayed cytotoxicity against MOLT-3 cell lines, except for p-methoxy analog 4d. Interestingly, the o-hydroxy derivative 4k was shown to be the most potent cytotoxic against HuCCA-1, A-549 and MOLT-3 cell lines. The lowest IC50 value of 1.23 μM was observed for MOLT-3 cells. Trimethoxy analog 4f exerted the most potent activity against HepG2 with an IC50 of 22.70 μM, which is lower than the reference drug, etoposide. QSAR studies showed that total symmetry index (Gu), 3D-MoRSE (Mor31v and Mor32u) and 3D Petitjean index (PJI3) were the most important descriptors accounting for the observed cytotoxicities. The most potent cytotoxic compound (4k) against MOLT-3 had the highest Gu value, correspondingly the inactive p-methoxy analog (4d) had the lowest Gu value. On the other hand, the highest molecular mass compound (4f) was shown to be the most potent cytotoxic against HepG2 cells. The studies disclose that tetrahydroisoquinolines 4f and 4k are potentially interesting lead pharmacophores that should be further explored. The QSAR models provided insights into the physicochemical properties of the investigated compounds. © 2013 The Pharmaceutical Society of Korea. | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (2 hydroxyphenyl)isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (3 hydroxy 4 methoxyphenyl)isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (3,4,5 trimethoxyphenyl)isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 bromophenyl)isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxy 3 methoxyphenyl)isoquinolone | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxy 3,5 dimethoxyphenyl)isoquinolone | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxyphenyl)isoquinolone | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 methoxyphenyl)isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 methylisoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 ohenylisoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl]isoquinoline | |
dc.subject | 1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4methylphenyl)sulfonyl] 1 (3 pyridyl)isoquinoline | |
dc.subject | doxorubicin | |
dc.subject | etoposide | |
dc.subject | n tosyl 1,2,3,4 tetrahydroisoquinoline derivative | |
dc.subject | tetrahydroisoquinoline derivative | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | bile duct carcinoma | |
dc.subject | cancer cell culture | |
dc.subject | cell strain HepG2 | |
dc.subject | controlled study | |
dc.subject | drug cytotoxicity | |
dc.subject | drug inhibition | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human cell culture | |
dc.subject | IC 50 | |
dc.subject | liver cell carcinoma | |
dc.subject | lung carcinoma | |
dc.subject | lymphatic leukemia | |
dc.subject | molecular weight | |
dc.subject | pharmacophore | |
dc.subject | physical chemistry | |
dc.subject | Pictet Spengler reaction | |
dc.subject | quantitative structure activity relation | |
dc.subject | Antineoplastic Agents | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Proliferation | |
dc.subject | Cell Survival | |
dc.subject | Drug Design | |
dc.subject | Drugs, Investigational | |
dc.subject | Humans | |
dc.subject | Hydroxylation | |
dc.subject | Inhibitory Concentration 50 | |
dc.subject | Magnetic Resonance Spectroscopy | |
dc.subject | Mass Spectrometry | |
dc.subject | Molecular Structure | |
dc.subject | Neoplasms | |
dc.subject | Physicochemical Phenomena | |
dc.subject | Quantitative Structure-Activity Relationship | |
dc.subject | Spectroscopy, Fourier Transform Infrared | |
dc.subject | Tetrahydroisoquinolines | |
dc.subject | Tosyl Compounds | |
dc.title | Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4- tetrahydroisoquinoline derivatives | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Archives of Pharmacal Research. Vol 36, No.9 (2013), p.1066-1077 | |
dc.identifier.doi | 10.1007/s12272-013-0111-9 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.